Prelude Therapeutics
PRLD
$3.93
Share price
0.77%
Change (1 day)
-29.32%
Change (1 year)
Categories
Prelude Therapeutics (PRLD) - Cash on Hand
Cash on Hand as of March 2024 : $0.20 B
According to Prelude Therapeutics's latest financial reports the company has $0.20 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Prelude Therapeutics - Cash on Hand chart (from 2019 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.23 B | 15.47% |
| 2022-12-31 | $0.20 B | -30.73% |
| 2021-12-31 | $0.29 B | 33.4% |
| 2020-12-31 | $0.21 B | 1056.36% |
| 2019-12-31 | $18.87 M | 21.06% |
| 2018-12-31 | $15.59 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 56.88% | 🇺🇸 USA |